Nemaura Medical Inc. (NMRD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.14 Million USD | -80.78% |
| 2022 | -13.88 Million USD | -121.88% |
| 2021 | -6.25 Million USD | -50.44% |
| 2020 | -4.16 Million USD | 6.57% |
| 2019 | -4.45 Million USD | -144.6% |
| 2018 | -1.82 Million USD | -17.35% |
| 2017 | -1.55 Million USD | -0.76% |
| 2016 | -1.53 Million USD | -16.65% |
| 2015 | -1.31 Million USD | -125.14% |
| 2014 | -586.23 Thousand USD | 29.42% |
| 2013 | -830.57 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.6 Million USD | -692.48% |
| 2024 Q3 | -2.16 Million USD | -79.61% |
| 2024 Q2 | -1.2 Million USD | 53.77% |
| 2023 Q2 | -3.85 Million USD | 32.92% |
| 2023 FY | -25.1 Million USD | -80.78% |
| 2023 Q4 | -328.48 Thousand USD | 88.27% |
| 2023 Q3 | -2.79 Million USD | 27.4% |
| 2023 Q1 | -5.74 Million USD | -4.65% |
| 2022 Q4 | -5.49 Million USD | -60.06% |
| 2022 Q1 | -3.34 Million USD | -56.94% |
| 2022 Q2 | -3.49 Million USD | -4.5% |
| 2022 Q3 | -3.43 Million USD | 1.79% |
| 2022 FY | -13.88 Million USD | -121.88% |
| 2021 Q3 | -1.44 Million USD | 8.51% |
| 2021 FY | -6.25 Million USD | -50.44% |
| 2021 Q4 | -2.13 Million USD | -47.28% |
| 2021 Q1 | -1.1 Million USD | 18.33% |
| 2021 Q2 | -1.58 Million USD | -43.74% |
| 2020 Q2 | -1.11 Million USD | 10.73% |
| 2020 Q1 | -1.25 Million USD | 22.97% |
| 2020 FY | -4.16 Million USD | 6.57% |
| 2020 Q4 | -1.34 Million USD | -202.67% |
| 2020 Q3 | -445 Thousand USD | 60.16% |
| 2019 Q1 | -763.15 Thousand USD | -37.94% |
| 2019 FY | -4.45 Million USD | -144.6% |
| 2019 Q4 | -1.62 Million USD | -75.45% |
| 2019 Q3 | -925.88 Thousand USD | 18.73% |
| 2019 Q2 | -1.13 Million USD | -49.29% |
| 2018 Q4 | -553.26 Thousand USD | -18.63% |
| 2018 Q3 | -466.36 Thousand USD | -18.66% |
| 2018 Q2 | -393.03 Thousand USD | 3.62% |
| 2018 Q1 | -407.78 Thousand USD | -13.52% |
| 2018 FY | -1.82 Million USD | -17.35% |
| 2017 FY | -1.55 Million USD | -0.76% |
| 2017 Q4 | -359.23 Thousand USD | 4.3% |
| 2017 Q3 | -375.36 Thousand USD | -16.4% |
| 2017 Q2 | -322.48 Thousand USD | 34.74% |
| 2017 Q1 | -494.18 Thousand USD | -18.31% |
| 2016 Q1 | -402.82 Thousand USD | 24.84% |
| 2016 FY | -1.53 Million USD | -16.65% |
| 2016 Q4 | -417.71 Thousand USD | -27.05% |
| 2016 Q3 | -328.78 Thousand USD | 15.76% |
| 2016 Q2 | -390.3 Thousand USD | 3.11% |
| 2015 Q4 | -535.93 Thousand USD | -237.57% |
| 2015 FY | -1.31 Million USD | -125.14% |
| 2015 Q1 | -269.25 Thousand USD | -66.07% |
| 2015 Q2 | -355.88 Thousand USD | -32.18% |
| 2015 Q3 | -158.76 Thousand USD | 55.39% |
| 2014 Q1 | -61.77 Thousand USD | 70.25% |
| 2014 Q3 | -340.19 Thousand USD | -1437.12% |
| 2014 Q4 | -162.12 Thousand USD | 52.34% |
| 2014 FY | -586.23 Thousand USD | 29.42% |
| 2014 Q2 | -22.13 Thousand USD | 64.17% |
| 2013 Q4 | -207.64 Thousand USD | 0.0% |
| 2013 FY | -830.57 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 82.68% |
| Cerus Corporation | -37.48 Million USD | 62.272% |
| OrthoPediatrics Corp. | -20.97 Million USD | 32.565% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -29.104% |
| Talis Biomedical Corporation | -62 Million USD | 77.19% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -4.128% |
| Inogen, Inc. | -102.44 Million USD | 86.194% |
| Spectral AI, Inc. | -20.85 Million USD | 32.177% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 76.728% |
| CVRx, Inc. | -41.19 Million USD | 65.67% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 2309.282% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -59.816% |
| Orthofix Medical Inc. | -151.39 Million USD | 90.658% |
| Venus Concept Inc. | -37.25 Million USD | 62.03% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 77.046% |
| Bioventus Inc. | -156.23 Million USD | 90.947% |
| BrainsWay Ltd. | -4.19 Million USD | -236.996% |
| Envoy Medical, Inc. | -29.9 Million USD | 52.709% |
| electroCore, Inc. | -18.83 Million USD | 24.903% |
| IceCure Medical Ltd | -14.65 Million USD | 3.469% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 73.144% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -2.899% |
| MaxCyte, Inc. | -37.92 Million USD | 62.704% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -19.261% |
| Nexalin Technology, Inc. | -4.64 Million USD | -204.251% |
| PAVmed Inc | -64.17 Million USD | 77.961% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 73.043% |
| RxSight, Inc. | -48.6 Million USD | 70.902% |
| Sight Sciences, Inc. | -55.54 Million USD | 74.537% |
| SI-BONE, Inc. | -43.33 Million USD | 67.363% |
| TELA Bio, Inc. | -46.66 Million USD | 69.69% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 76.043% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 71.442% |
| LivaNova PLC | 17.54 Million USD | 180.609% |
| 908 Devices Inc. | -36.39 Million USD | 61.143% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 92.422% |
| NeuroPace, Inc. | -32.95 Million USD | 57.083% |
| LENSAR, Inc. | -14.38 Million USD | 1.664% |
| Apyx Medical Corporation | -18.71 Million USD | 24.418% |
| Cutera, Inc. | -162.83 Million USD | 91.314% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -30.598% |
| BioSig Technologies, Inc. | -29.04 Million USD | 51.297% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 82.891% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 35.969% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 120.879% |
| Axonics, Inc. | -6.08 Million USD | -132.322% |
| Outset Medical, Inc. | -172.79 Million USD | 91.815% |
| IRIDEX Corporation | -9.57 Million USD | -47.792% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 86.644% |
| IRadimed Corporation | 17.19 Million USD | 182.266% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -71.564% |
| INVO Bioscience, Inc. | -8.03 Million USD | -76.035% |
| Telesis Bio, Inc. | -47.72 Million USD | 70.363% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 238.082% |
| Varex Imaging Corporation | -47.7 Million USD | 70.349% |
| Quipt Home Medical Corp. | -2.78 Million USD | -408.036% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -25.321% |
| Pulmonx Corporation | -60.84 Million USD | 76.754% |
| Dynatronics Corporation | -2.69 Million USD | -424.285% |
| Modular Medical, Inc. | -17.47 Million USD | 19.04% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -24.209% |
| Semler Scientific, Inc. | 20.58 Million USD | 168.716% |
| InMode Ltd. | 197.91 Million USD | 107.146% |
| Bruker Corporation | 427.2 Million USD | 103.311% |
| Cytosorbents Corporation | -28.5 Million USD | 50.386% |
| DexCom, Inc. | 541.5 Million USD | 102.612% |
| Align Technology, Inc. | 445.05 Million USD | 103.178% |
| Viveve Medical, Inc. | -22.02 Million USD | 35.789% |
| ZimVie Inc. | -393.28 Million USD | 96.404% |
| Movano Inc. | -29.28 Million USD | 51.7% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -16.429% |
| Nexalin Technology, Inc. | -4.64 Million USD | -204.251% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 2309.282% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 93.646% |
| Profound Medical Corp. | -28.56 Million USD | 50.493% |
| Insulet Corporation | 206.3 Million USD | 106.856% |
| enVVeno Medical Corporation | -23.51 Million USD | 39.855% |
| Surmodics, Inc. | -11.54 Million USD | -22.541% |
| iCAD, Inc. | -4.84 Million USD | -191.804% |
| Nuwellis, Inc. | -20.2 Million USD | 30.013% |
| Biotricity, Inc. | -14.09 Million USD | -0.351% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 88.539% |
| Aethlon Medical, Inc. | -12.2 Million USD | -15.855% |
| InspireMD, Inc. | -19.91 Million USD | 28.983% |
| PAVmed Inc. | -64.17 Million USD | 77.961% |
| BIOLASE, Inc. | -20.63 Million USD | 31.448% |
| Beyond Air, Inc. | -60.24 Million USD | 76.522% |
| FONAR Corporation | 10.56 Million USD | 233.843% |
| AxoGen, Inc. | -21.71 Million USD | 34.87% |
| Vivani Medical, Inc. | -25.65 Million USD | 44.863% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 149.601% |
| Inari Medical, Inc. | -1.63 Million USD | -764.531% |
| UFP Technologies, Inc. | 44.92 Million USD | 131.484% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -175.581% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -114.13% |
| Tenon Medical, Inc. | -15.58 Million USD | 9.224% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 8.312% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 59.97% |
| AdaptHealth Corp. | -678.89 Million USD | 97.917% |
| Sintx Technologies, Inc. | -8.25 Million USD | -71.252% |
| NanoVibronix, Inc. | -3.71 Million USD | -281.13% |
| Quanterix Corporation | -32.33 Million USD | 56.257% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -25.321% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 3016.234% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 95.389% |
| TransMedics Group, Inc. | -25.02 Million USD | 43.488% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 36.097% |
| NeuroMetrix, Inc. | -6.52 Million USD | -116.613% |
| Hyperfine, Inc. | -44.23 Million USD | 68.028% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 81.983% |
| Biomerica, Inc. | -5.97 Million USD | -136.596% |
| Bone Biologics Corporation | -8.94 Million USD | -58.053% |
| AVITA Medical, Inc. | -39.16 Million USD | 63.89% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -42.093% |
| Silk Road Medical, Inc | -55.74 Million USD | 74.627% |